Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
| Autor: | Ghisoni, E., Wicky, A., Bouchaab, H., Imbimbo, M., Delyon, J., Gautron Moura, B., Gérard, C.L., Latifyan, S., Özdemir, B.C., Caikovski, M., Pradervand, S., Tavazzi, E., Gatta, R., Marandino, L., Valabrega, G., Aglietta, M., Obeid, M., Homicsko, K., Mederos Alfonso, N.N., Zimmermann, S., Coukos, G., Peters, S., Cuendet, M.A., Di Maio, M., Michielin, O. |
|---|---|
| Zdroj: | In European Journal of Cancer May 2021 149:153-164 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect